Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Antibody drug conjugates (ADCs) are an efficacious class of anti-cancer drugs that comprise monoclonal antibodies (mAbs) conjugated to small-molecule cytotoxic agent via a stable linker. This review summarizes the current knowledge and developments in the field of ADCs.
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Portland Press Ltd.
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613712/ |